Skip to main content
    E

    Emerson Electric Company (EMR)

    Official site

    INDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE

    $159.29
    -1.36 (-0.85%)

    Market Cap: $88.13B

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Emerson Electric Company (EMR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Emerson Electric Company (EMR) has a market cap of $88.13B and an enterprise value of $98.50B. Its trailing P/E is 24.2x.

    Total Valuation

    Enterprise value is 11.77% above the market cap, as debt exceeds cash.

    Market Cap$88.13B
    Enterprise Value$98.50B
    Latest price (Nov 17, 2026)$159.29

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateNov 13, 2026
    Next Payment DateDec 10, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count fell 0.36% in the quarter ended Jun 30, 2026 and shrank 1.15% a year over 2 years.

    Shares Outstanding559.60M
    Shares Change (YoY)-0.59%
    Shares Change (QoQ)-0.36%
    Share Count Growth (2Y CAGR)-1.15%

    Valuation Ratios

    Sales and book value multiples are 4.7x and 4.3x. Its year-end P/E ranged from 18.3x to 26.2x from 2016 to 2025.

    P/E Ratio24.2x
    Forward P/E21.6x
    P/S Ratio4.7x
    Forward P/S4.4x
    P/B Ratio4.3x
    P/FCF Ratio25.2x
    P/OCF Ratio22.2x
    PEG Ratio2.2

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 18.8x EBITDA and 28.1x free cash flow.

    EV / Earnings36.6x
    EV / Sales5.2x
    EV / EBITDA18.8x
    EV / EBIT25.8x
    EV / FCF28.1x

    Price Statistics

    The stock is up 25.32% over 52 weeks and trades 0.03% below its 50-day average.

    Beta (1Y)1.52
    52-Week Change+25.32%
    1-Month Change-0.42%
    3-Month Change+1.43%
    6-Month Change+22.34%
    5-Year Change+70.02%
    10-Year Change+225.45%
    Total Return (1Y)+27.10%
    Total Return (3Y CAGR)+22.56%
    Total Return (5Y CAGR)+12.75%
    Return vs SPY (1Y)+14.58%
    Max Drawdown (1Y)-23.72%
    Max Drawdown (3Y)-29.61%
    Sharpe Ratio (1Y)0.73
    Correlation with SPY (1Y)0.65
    50-Day Average$159.33
    200-Day Average$147.31
    52-Week Range$121.30 to $171.39
    RSI (14 Days)43.8
    Average Volume (20 Days)3.04M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.94x current liabilities, and total debt is 0.59x shareholder equity.

    Current Ratio0.94x
    Quick Ratio0.70x
    Debt / Equity0.59x
    Debt / EBITDA2.30x
    Debt / FCF3.44x
    Interest Coverage-25.84x

    Returns and Efficiency

    Return on invested capital is 8.96% over the last 12 months, against a 5-year average of 7.43%.

    Return on Equity (ROE)12.98%
    Return on Assets (ROA)6.44%
    Return on Invested Capital (ROIC)8.96%
    Return on Capital Employed (ROCE)12.06%
    ROE (5Y Average)25.60%
    ROA (5Y Average)11.22%
    ROIC (5Y Average)7.43%
    Asset Turnover0.45x
    Inventory Turnover3.58x
    Receivables Turnover5.96x
    Cash Conversion Cycle95 days

    Taxes

    Income tax took 22.81% of pretax income over the last 12 months.

    Income Tax (TTM)$796.00M
    Effective Tax Rate22.81%

    Scores

    EMR has an Altman Z-Score of 4.68, in the safe zone above 2.99, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.

    Altman Z-Score4.68
    Altman Z ZoneSafe
    Piotroski F-Score9 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $18.98B over the last 12 months is up 5.36% from the 12 months before.

    Revenue$18.98B
    Revenue Growth (YoY)+5.36%
    Gross Profit$10.13B
    Operating Income$3.82B
    Pretax Income$3.49B
    Net Income$2.69B
    EBITDA$5.30B
    EBIT$3.82B
    Reported EPS (TTM)$6.57

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 49.61% of the $41.81B in total assets.

    Cash and Equivalents$1.81B
    Total Debt$12.18B
    Net Debt$10.37B
    Net Debt Per Share$18.53
    Working Capital-$601.00M
    Shareholder Equity$20.74B
    Book Value Per Share$37.06
    Tangible Book Value-$5.81B
    Total Assets$41.81B
    Total Liabilities$21.06B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $443.00M of capital spending, operating cash flow left $3.54B of free cash flow.

    Operating Cash Flow$3.98B
    Capital Expenditures$443.00M
    Free Cash Flow$3.54B
    FCF Per Share$6.34
    Depreciation and Amortization$1.48B
    Dividends Paid$1.24B
    Share Repurchases$1.00B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 20.14%, against a 5-year average of 16.92%.

    Gross Margin53.36%
    Operating Margin20.14%
    Pretax Margin18.38%
    Net Margin14.19%
    EBITDA Margin27.93%
    EBIT Margin20.14%
    FCF Margin18.62%
    Gross Margin (5Y Average)50.33%
    Operating Margin (5Y Average)16.92%
    Net Margin (5Y Average)29.64%

    Growth

    Revenue grew 7.77% a year over 3 years, and EPS 13.87% a year.

    Revenue Growth (3Y CAGR)+7.77%
    Revenue Growth (5Y CAGR)+7.98%
    EPS Growth (3Y CAGR)+13.87%
    EPS Growth (5Y CAGR)+9.89%
    FCF Growth (3Y CAGR)+134.54%
    FCF Growth (5Y CAGR)+2.20%
    Operating Income Growth (3Y CAGR)+11.81%
    Book Value Per Share Growth (2Y CAGR)-0.19%

    Revenue and profit by year

    Dividends and Yields

    EMR pays out 31.79% of earnings as dividends.

    Dividend Per Share (Annual)$2.38
    Dividend Yield1.49%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+1.16%
    Dividend Growth (5Y CAGR)+1.29%
    Payout Ratio31.79%
    FCF Payout Ratio35.19%
    Earnings Yield4.13%
    FCF Yield3.97%
    Buyback Yield1.12%
    Shareholder Yield2.52%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Dec 12, 2006.

    Last Split DateDec 12, 2006
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, EMR has the 8th highest P/E and the 5th highest P/S.

    P/E Ratio24.2x vs 25.2x median
    P/S Ratio4.7x vs 4.0x median
    ROIC8.96% vs 11.37% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.36% vs +8.10% median
    Dividend Yield1.49% vs 1.10% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.31% and EPS growth at 10.57% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.31%
    EPS Growth Forecast (2Y CAGR)+10.57%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EMR

    What is EMR's market cap?

    Emerson Electric Company has a market cap of $88.13B. Its enterprise value, which adds debt and subtracts cash, is $98.50B.

    What is EMR's P/E ratio?

    Emerson Electric Company has a trailing P/E ratio of 24.2x and a forward P/E of 21.6x.

    How many shares of EMR are outstanding?

    Emerson Electric Company has 559.60M shares outstanding. The count is down 0.59% from a year earlier.

    Does EMR pay a dividend?

    Yes. Emerson Electric Company pays $2.38 a share a year, a dividend yield of 1.49%.

    How much debt does EMR have?

    Emerson Electric Company has $12.18B of total debt and $1.81B of cash and equivalents, a net debt position of $10.37B.